Skip to main content

Table 1 Patients characteristics, Gleason score, BMD categories of case and control groups, the mean BMD, decreasing trend of BMD pre- and post-ADT

From: Bone mineral density in Nigerian men on androgen deprivation therapy for advanced prostate cancer

  Cases (n = 77) Control n (77) Total Statistics
Age groups (years)
 51–60 11 (14.3) 13 (16.9) 24 (15.6) p = 0.283
 61–70 32 (41.6) 32 (41.6) 64 (41.6)  
 71–80 28 (36.4) 27 (35.1) 55 (35.1)  
 81–90 6 (7.8) 5 (6.5) 11 (6.5)  
 Mean ± SD 70.15 ± 6.7 68.92 ± 8.5   
BMI     p = 0.578
 < 18.5 4 (5.2) 3 (3.9) 7 (4.5)  
 18.5–24.9 48 (62.3) 56 (72.7) 104 (67.5)  
 25.0–29.9 19 (24.7) 13 (16.9) 32 (20.8)  
 ≥ 30.0 6 (7.8) 5 (6.5) 11 (7.1)  
BMD group
 Normal (> − 1) 43 (55.8) 55 (71.4) 98 (63.6)  
 Osteopenia (− 1 to − 2.5) 23 (29.9) 19 (24.7) 42 (27.3) p = 0.039
 Osteoporosis (< − 2.5) 11 (14.3) 3 (3.9) 14 (9.1)  
 Mean BMD T score − 0.78 ± 1.7 0.26 ± 1.5   p = 0.044